MedPath

Sleep Disorders in Patients With Suspected Lung Cancer Before and After Thoracic Surgery

Conditions
Lung Cancer
Registration Number
NCT04759651
Lead Sponsor
Koç University
Brief Summary

The main aim of this study is to prospectively evaluate the occurrence of sleep disorders in patients undergoing thoracic surgery due to the preliminary diagnosis of lung cancer. Secondary aims include anxiety, depressive mood and functional outcomes before and 3 months after the intervention.

Detailed Description

Cancer surgery is one of the traumas that affect human life, starting from diagnostic procedures, along with the recovery process. Although 5-year survival in lung cancer has increased to 60%, there is a general prejudice that lung cancer has a poor prognosis. A preliminary diagnosis of a such condition has consequently a negative effect on the mood and sleep patterns of the patients, starting already from the beginning of the diagnostic procedures. In our study, we want to evaluate the occurrence of sleep disorders, anxiety, depressive mood and functional outcomes before and 3 months after the surgical intervention. This would also help us to better identify the patients in need for professional support for sleep disorders as well as psychiatric conditions, and thus, a better management of patients with lung cancer.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1200
Inclusion Criteria
  • Patients who will undergo lung resection with a pre-diagnosis of lung cancer
  • Being literate or having the physical strength to answer questions.
Exclusion Criteria
  • The patient has a chronic disease such as dementia or treatment-resistant schizophrenia in which reality assessment is impaired.
  • Patients who have received chemotherapy and / or radiotherapy due to their previous disease.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change from baseline in Restless Legs Syndrome questionnaire scores3 months

Restless Leg Syndrome questionnaire. Score range: 0-4 points, with higher scores indicating more severe symptoms

Change from baseline in Insomnia questionnaire scores3 months

Insomnia questionnaire. Score range: 0-28 points, with higher scores indicating greater insomnia severity.

Change from baseline in Epworth Sleepiness Scale scores3 months

Excessive daytime sleepiness. Score range: 0-24 points, with higher scores indicating greater daytime sleepiness. Scores ≥11 are generally considered to be abnormal, or positive for excessive daytime sleepiness.

Change from baseline in Berlin Questionnaire scores3 months

High-risk Obstructive Sleep Apnea. Patients can be classified into High Risk or Low Risk based on their responses to the individual items and their overall scores in the symptom categories.

Change from baseline in Functional Outcome of Sleep Questionnaire scores3 months

Sleep related quality of life. Score range: 5-20 points, with higher scores indicating better functional status.

Change from baseline in STOP-BANG questionnaire scores3 months

High-risk Obstructive Sleep Apnea. Score range: 0-8 points, patients with a STOP-Bang score of 0 to 2 can be classified as low risk for moderate to severe OSA whereas those with a score of 5 to 8 can be classified as high risk for moderate to severe OSA.

The STOP-BANG is an assessment tool used to help diagnose Obstructive Sleep Apnea

Secondary Outcome Measures
NameTimeMethod
Change from baseline in Beck Anxiety Inventory scores3 months

Self-rating anxiety scale. Score range: 0-63 points, a total score of 0 - 7 is interpreted as a "Minimal" level of anxiety; 8 - 15 as "Mild"; 16 - 25 as "Moderate", and; 26 - 63 as "Severe".

Change from baseline in Zung Self-rating Depression Scale scores3 months

Zung Self-rating Depression Scale. Score range: 0-80 points, most people with depression score between 50 and 69, while a score of 70 and above indicates severe depression.

Trial Locations

Locations (1)

Koç University Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath